Overview Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project Status: Completed Trial end date: 2016-03-01 Target enrollment: Participant gender: Summary Determine if a cystatin C-inclusive vancomycin dosing algorithm improved target trough achievement compared to creatinine clearance-guided vancomycin therapy in critically ill patients. Phase: Phase 1 Details Lead Sponsor: Mayo ClinicTreatments: CystatinsVancomycin